ANAB
AnaptysBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$56.80
−1.15%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+12.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Lizzul Paul F. · officer: Chief Medical Officer | A-Award | 16,667 | $0.00 |
| Aug 7, 2026 | Faga Daniel · director, officer: President, CEO | A-Award | 53,334 | $0.00 |
| Jun 17, 2026 | Orwin John A · director | M-Exempt | 6,030 | $0.00 |
| Jun 17, 2026 | RENTON HOLLINGS · director | M-Exempt | 6,030 | $0.00 |
| Jun 17, 2026 | Schmid John P. · director | M-Exempt | 6,030 | $0.00 |
| May 13, 2026 | Murphy Christopher M. · officer: Chief Financial Officer | A-Award | 25,765 | $0.00 |
| May 13, 2026 | Hughes Owen · director | A-Award | 11,250 | $0.00 |
| Apr 29, 2026 | GRAY SUSANNAH · director | A-Award | 11,250 | $0.00 |
| Apr 22, 2026 | RENTON HOLLINGS · director | A-Award | 9,200 | $22 |
| Apr 22, 2026 | Schmid John P. · director | A-Award | 9,200 | $22 |
| Apr 22, 2026 | RENTON HOLLINGS · director | A-Award | 15,000 | $18 |
| Apr 22, 2026 | Faga Daniel · director, officer: President, CEO | A-Award | 9,200 | $22 |
| Apr 22, 2026 | RENTON HOLLINGS · director | A-Award | 11,000 | $12 |
| Apr 22, 2026 | Orwin John A · director | A-Award | 10,600 | $14 |
| Apr 22, 2026 | RENTON HOLLINGS · director | A-Award | 6,000 | $77 |
| Apr 22, 2026 | Schmid John P. · director | A-Award | 11,000 | $12 |
| Apr 22, 2026 | RENTON HOLLINGS · director | A-Award | 10,600 | $17 |
| Apr 22, 2026 | Schmid John P. · director | A-Award | 15,000 | $18 |
| Apr 22, 2026 | Schmid John P. · director | A-Award | 10,600 | $17 |
| Apr 22, 2026 | Faga Daniel · director, officer: President, CEO | A-Award | 133,400 | $32 |
| Apr 22, 2026 | Orwin John A · director | A-Award | 3,311 | $14 |
| Apr 22, 2026 | Schmid John P. · director | A-Award | 16,510 | $16 |
| Apr 22, 2026 | Faga Daniel · director, officer: President, CEO | A-Award | 11,000 | $23 |
| Apr 22, 2026 | Schmid John P. · director | A-Award | 6,000 | $77 |
| Apr 22, 2026 | RENTON HOLLINGS · director | A-Award | 5,500 | $32 |
| Apr 22, 2026 | Orwin John A · director | A-Award | 16,510 | $16 |
| Apr 22, 2026 | Faga Daniel · director, officer: President, CEO | A-Award | 2,321 | $23 |
| Apr 22, 2026 | Faga Daniel · director, officer: President, CEO | A-Award | 379,620 | $16 |
| Apr 22, 2026 | Faga Daniel · director, officer: President, CEO | A-Award | 194,900 | $17 |
| Apr 22, 2026 | RENTON HOLLINGS · director | A-Award | 16,510 | $16 |
Institutional positioning
13F filings over the trailing two quarters
New 98Increased 131Reduced 139Sold out 35
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ECOR1 CAPITAL, LLC | Unchanged | 7,880,094 | May 15, 2026 |
| EcoR1 Capital, LLC | Unchanged | 7,880,094 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 1,844,049 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 1,681,380 | May 13, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 1,330,879 | Aug 14, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Reduced | 1,330,879 | May 15, 2026 |
| STATE STREET CORP | Increased | 1,286,194 | Aug 7, 2026 |
| MORGAN STANLEY | Reduced | 993,905 | May 15, 2026 |
| STATE STREET CORP | Reduced | 992,445 | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Increased | 940,000 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 906,233 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 853,151 | May 15, 2026 |
| Affinity Asset Advisors, LLC | Reduced | 826,109 | Aug 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 822,316 | Aug 14, 2026 |
| Sanofi | Unchanged | 821,917 | Jul 28, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 7, 2026